Parálisis Periódica Hipocalémica Tirotóxica Aporte del laboratorio en un nuevo desafío diagnostico
Vol. 32 Núm. 4 (2015), Revisiones
Vol. 32 Núm. 4 (2015)

Parálisis Periódica Hipocalémica Tirotóxica Aporte del laboratorio en un nuevo desafío diagnostico

Revisiones
Publicado 2015-06-07
Ruth Gloria Shocron
Socia Titular-BIoquimica
Melina Bianconi
PDF

Palabras clave

parálisis periódica tirotóxica
tiroiditis
hipocalemia
hipertiroidismo

Cómo citar

1.
Shocron RG, Bianconi M. Parálisis Periódica Hipocalémica Tirotóxica Aporte del laboratorio en un nuevo desafío diagnostico. Rev Arg de Ter Int. [Internet]. 7 de junio de 2015 [citado 25 de abril de 2024];32(4). Disponible en: https://revista.sati.org.ar/index.php/MI/article/view/417
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Descargar cita

Endnote/Zotero/Mendeley (RIS) BibTeX

Resumen

La Parálisis Periódica Tirotóxica Hipocalémica es una patología  de muy baja frecuencia en Argentina, no obstante, es muy  importante tenerla en cuenta como urgencia, ya que puede ser fatal de no hacerse  en forma oportuna el diagnostico y tratamiento correcto. El objetivo de esta investigación es  destacar el aumento de  incidencia de una enfermedad en las salas de guardia de nuestro país, potencialmente fatal y a la vez fácilmente reversible con el tratamiento adecuado y oportuno, a fin de  tenerse en cuenta en las sospechas diagnósticas de emergencia y el aporte que puede hacer el bioquímico, desde un servicio de urgencia, para ayudar al diagnostico  en forma rápida y certera.

Summary:

Hypokalemic Thyrotoxic  Periodic Paralysis  is a disease of very low frequency in Argentina, however, it is very important to take it into account as an emergency, because if it is not timely diagnosed and correctly treatment it can be fatal. The objective of this research is to distinguish the disease´s increased incidence in the emergency rooms of our country, which is potentially fatal, and at the same time it is easily reversible with proper and timely treatment, to be considered in the emergency diagnostic suspicion and the contribution that the biochemist can make from an emergency service to subserve the diagnosis quickly and accurately.

PDF

Citas

<!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves /> <w:TrackFormatting /> <w:HyphenationZone>21</w:HyphenationZone> <w:PunctuationKerning /> <w:ValidateAgainstSchemas /> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF /> <w:LidThemeOther>ES</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables /> <w:SnapToGridInCell /> <w:WrapTextWithPunct /> <w:UseAsianBreakRules /> <w:DontGrowAutofit /> <w:SplitPgBreakAndParaMark /> <w:DontVertAlignCellWithSp /> <w:DontBreakConstrainedForcedTables /> <w:DontVertAlignInTxbx /> <w:Word11KerningPairs /> <w:CachedColBalance /> </w:Compatibility> <m:mathPr> <m:mathFont m:val="Cambria Math" /> <m:brkBin m:val="before" /> <m:brkBinSub m:val=" " /> <m:smallFrac m:val="off" /> <m:dispDef /> <m:lMargin m:val="0" /> <m:rMargin m:val="0" /> <m:defJc m:val="centerGroup" /> <m:wrapIndent m:val="1440" /> <m:intLim m:val="subSup" /> <m:naryLim m:val="undOvr" /> </m:mathPr></w:WordDocument> </xml><![endif]--> <p class="MsoNormal" style="text-align: justify; line-height: 115%; mso-outline-level: 1;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US"> Lin SH, Lin YF, Halpering ML. Hypokalemia and paraly&shy;sis. QJM 2001; 94: 133-9.</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 115%; mso-outline-level: 1;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;" lang="EN-US">Maurya PK, Kalita J, Misra UK</span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US">. Spectrum of hypokalaemic periodic paralysis in a tertiary care centre in India. <em>Postgrad Med J</em> 2010; 86: 692-695.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;" lang="EN-US">Phakdeekitcharoen B, Ruangraksa C, Radinahamed P</span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US">. Hypokalaemia and paralysis in the Thai population. <em>Nephrol Dial Transplant</em> 2004; 19: 2013-2018.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoListParagraphCxSpFirst" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;" lang="EN-US">Pothiwala P, Levine SN</span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US">. Analytic review: thyrotoxic periodic paralysis: a review. <em>J Intensive Care </em></span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><em><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp; </span>Med</span></em><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"> 2010; 25: 71-77.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: ES;">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;" lang="EN-US">Kung AW</span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US">. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. <em>J Clin Endocrinol </em></span></p> <p class="MsoEndnoteText" style="text-align: justify;"><em><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;</span>Metab</span></em><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"> 2006; 91: 2490-2495.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: ES;">&nbsp;</span></p> <p class="MsoNormal"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US">McFadzean, A. J., and Yeung R. "Periodic paralysis complicating thyrotoxicosis in Chinese." <em>British medical journal</em> 1.5538 (1967): 451.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"> D&iacute;as DA, Silva MR, Chiamolera MI, Kasamatsu TS, Cerutti JM, Maciel RM. Paralisia Peri&oacute;dica <span style="mso-spacerun: yes;">&nbsp;&nbsp;</span>Hipocal&eacute;&shy;mica Tirot&oacute;xica, Uma Urgencia End&oacute;crina: Revis&atilde;o do Quadro Cl&iacute;nico e Gen&eacute;tico de 25<span style="mso-spacerun: yes;">&nbsp;&nbsp; </span>Pacientes. Arq Bras Endocrinol Metab 2004; 48: 196-215.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: ES;">&nbsp;</span></p> <p class="MsoNormal"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US">Kung, Annie WC. "Thyrotoxic periodic paralysis: a diagnostic challenge." <span style="mso-bidi-font-style: italic;">The Journal of Clinical Endocrinology &amp; Metabolism</span> 91.7 (2006): 2490-2495.</span></p> <p class="MsoListParagraph" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoNormal"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"> <span style="color: black; mso-bidi-font-weight: bold;">Aparicio MM, Ballarino MC, Bertini K, Mallea Gil MS, Ridruejo MC<strong>. </strong></span><span style="color: black;">Tirotoxicosis y par&aacute;lisis </span></span></p> <p class="MsoListParagraph" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black;" lang="ES-AR"><span style="mso-spacerun: yes;">&nbsp; </span>peri&oacute;dica. Alta frecuencia en nuestro medio. </span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US">Rev Argent Endocrinol Metab </span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;" lang="EN-US">Sup</span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US"> 44 (2007).</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US"> Lin YF, Wu CC, Pei D, Chu SJ, Lin SH. Diagnostic Thyro&shy;toxic Periodic Paralysis in the ED. </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR">Am J </span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>Emerg Med 2003; 21: 339-42</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: ES;">&nbsp;</span></p> <p class="MsoListParagraphCxSpFirst" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US">Stedwell RE, Allen KM, Binder LS. Hypokalemic paraly&shy;ses: A review of the etiologies, </span></p> <p class="MsoListParagraphCxSpLast" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>pathophysiology, presen&shy;tation and therapy. Am J Emerg Med 1992; 10: 143-6.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: ES; mso-fareast-language: ES; mso-bidi-language: AR-SA;">Magsino e, RyanJ. Thyrotoxic periodic paralysis. South Med J 2000; 93:996-1003</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: ES;">&nbsp;</span></p> <p class="MsoNormal" style="text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"> </span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #231f20; mso-ansi-language: ES; mso-fareast-language: ES; mso-bidi-language: AR-SA;">Neisser Morales-Victorino, Luis Guevara-Arnal,<span style="mso-spacerun: yes;">&nbsp; </span>Paloma Almeda-Vald&eacute;s. Par&aacute;lisis </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #231f20; mso-ansi-language: ES; mso-fareast-language: ES; mso-bidi-language: AR-SA;"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>tirot&oacute;xica. Informe de un caso y revisi&oacute;n de la literatura. <span style="mso-spacerun: yes;">&nbsp;</span><span style="mso-bidi-font-weight: bold;">Revista de Investigaci&oacute;n M&eacute;dica Sur 2008;</span></span></p> <p class="MsoNormal" style="text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #231f20; mso-ansi-language: ES; mso-fareast-language: ES; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>2: 81-85. </span></p> <p class="MsoNormal" style="text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: ES;">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US">Ober, K. Thyrotoxic<span style="mso-spacerun: yes;">&nbsp;&nbsp; </span>periodic paralysis in t he United States. Report of 7 cases and review of the </span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>literatura. Medicine 1992; 71:109-1 18</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: ES;">&nbsp;</span></p> <p class="MsoListParagraphCxSpFirst" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US"> Ryan DP, Dias Da Silva MR, Soong TW, et al. Mutations in Potassium Channel Kir2. 6 Cause </span></p> <p class="MsoListParagraphCxSpLast" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>Susceptibility to Thyrotoxic Periodic Paralysis. Cell 2010; 140:88-98.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US">Chan A, Shinde R, Chow CC, Cockram CS, Swamina&shy;than R. In vivo and in vitro sodium pump </span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>activity in subjects with thyrotoxic periodic paralysis. Br Med J 1991; 303: 1096-9.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoListParagraphCxSpFirst" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US">Shih-Hua Lin* and Chou-Long Huang&dagger;. Mechanism of Thyrotoxic Periodic Paralysis. J Am Soc </span></p> <p class="MsoListParagraphCxSpLast" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>Nephrol 2012; 23: 985&ndash;988.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoNormal"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US">Harrison, AP and Clausen, T. "Thyroid hormone-induced upregulation of Na+ channels and Na+-K+ pumps: <span style="mso-spacerun: yes;">&nbsp;</span></span></p> <p class="MsoNormal"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>implications for contractility." <span style="mso-bidi-font-style: italic;">American Journal of Physiology-Regulatory, Integrative and Comparative </span></span></p> <p class="MsoNormal"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>Physiology</span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US"> 274.3 (1998): R864-R867.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoListParagraphCxSpFirst" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US">Soonthornpun S, Setasuban W, Thamprasit A. Insulin resistance in subjects with a history of </span></p> <p class="MsoListParagraphCxSpLast" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp; </span>thyrotoxic periodic paralysis. Clin Endocrinol (Oxf) 2009; 70:794-7.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US"> Kung</span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #231f20; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"> AW. Thyrotoxic periodic paralysis: A diagnostic Challenge. <em>J Clin Endocrinol Metab </em>2006; </span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #231f20; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp; </span>91: 2490-2495</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: ES;">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US">Goldberger ZD. An Electrocardiogram Triad in Thyro&shy;toxic Hypokalemic Periodic Paralysis. </span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp; </span><span style="mso-spacerun: yes;">&nbsp;</span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black;" lang="ES-AR">Circulation 2007; 115: e179-e180.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: ES;">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #231f20; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US">Lin SH, Chu P, Cheng CJ et al. Early diagnosis of thyrotoxic periodic paralysis: Spot urine calcium </span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #231f20; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp; </span><span style="mso-spacerun: yes;">&nbsp;</span>to phosphate ratio. <em>Crit. Care Med </em>2006; 34: 2984-2989</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">Lien, Y.H.H.</span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #231f20; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"> A new diagnostic test for an old diagnostic challenge: Thyrotoxic periodic paralysis.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #231f20; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp; </span><span style="mso-spacerun: yes;">&nbsp;</span><em>Crit Care Med </em>2006; </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-font-style: italic;" lang="EN-US">Critical care medicine</span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US"> 34.12 (2006): 3053-3054<span style="background: silver; mso-highlight: silver;">.</span></span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span class="element-citation"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">Lin SH, Chiu JS, Hsu CW, et al. A simple and rapid approach to hypokalemic paralysis. </span></span><span class="ref-journal"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">Am J</span></span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span class="ref-journal"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp; </span><span style="mso-spacerun: yes;">&nbsp;</span><span style="mso-spacerun: yes;">&nbsp;</span>Emerg Med </span></span><span class="element-citation"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">2003;</span></span><span class="ref-vol"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US"> 21:487</span></span><span class="element-citation"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&ndash;491.</span></span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoListParagraphCxSpFirst" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US">Lin SH, Lin YF, Chen DT, Chu P, Hsu CW, Halperin ML. Laboratory Tests to Determine the Cause </span></p> <p class="MsoListParagraphCxSpLast" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp; </span><span style="mso-spacerun: yes;">&nbsp;</span>of Hypokale&shy;mia and Paralysis. Arch Intern Med 2004; 164: 1561-6.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoNormal" style="text-align: justify; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;" lang="EN-US">Lu KC, Hsu YJ, Chiu JS, Hsu YD, Lin SH<strong> </strong></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US">2004 Effects of potassium supplementation on the </span></p> <p class="MsoNormal" style="text-align: justify; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>recovery of thyrotoxic periodic paralysis. </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-font-style: italic;" lang="EN-US">The American journal of emergency medicine</span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US"> 22.7 (2004): 544-547.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoNormal" style="text-align: justify; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US">Birkhahn RH, Gaeta TJ, Melniker L. Thyrotoxic periodic paralysis and intravenous propranolol in </span></p> <p class="MsoNormal" style="text-align: justify; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; mso-ansi-language: EN-US;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>the emergency setting. J Emerg Med 2000; 18: 199-202.</span></p> <p class="MsoEndnoteText" style="text-align: justify;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoListParagraphCxSpFirst" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US">Yu TS, Tseng CF, Chuang YY, Yeung LK, Lu KC. Potassium chloride supplementation alone may </span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>not improve hypokalemia in thyrotoxic hypokalemic periodic paralysis. J Emerg Med 2007;<span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>32:263-5.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left: 0cm; mso-add-space: auto; text-align: justify; line-height: 115%; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="EN-US">&nbsp;</span></p> <p class="MsoNormal" style="text-align: justify; mso-layout-grid-align: none; text-autospace: none;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;" lang="ES-AR"><span style="mso-special-character: footnote;"><span class="MsoEndnoteReference"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: &quot;Times New Roman&quot;; mso-ansi-language: ES-AR; mso-fareast-language: EN-US; mso-bidi-language: EN-US;" lang="ES-AR">[1]</span></span></span></span></span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US;" lang="ES-AR"> </span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;" lang="EN-US">Chen DY, Schneider PF, Zhang XS, He ZM, Chen TH</span><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US">. Fatality after cardiac arrest in thyrotoxic </span></p> <p class="MsoNormal" style="text-align: justify; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>periodic paralysis due to profound hypokalemia resulting from intravenous glucose administration </span></p> <p class="MsoNormal" style="text-align: justify; mso-layout-grid-align: none; text-autospace: none;"><span style="font-size: 9.0pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US"><span style="mso-spacerun: yes;">&nbsp;&nbsp;&nbsp; </span>and inadequate potassium replacement.<em> Thyroid</em> 2012; 22: 969-972</span><span style="font-size: 10.0pt; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: ES; mso-bidi-language: AR-SA;" lang="EN-US">.</span></p> <!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true" DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Normal" /> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 1" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9" /> <w:LsdException Locked="false" Priority="39" Name="toc 1" /> <w:LsdException Locked="false" Priority="39" Name="toc 2" /> <w:LsdException Locked="false" Priority="39" Name="toc 3" /> <w:LsdException Locked="false" Priority="39" Name="toc 4" /> <w:LsdException Locked="false" Priority="39" Name="toc 5" /> <w:LsdException Locked="false" Priority="39" Name="toc 6" /> <w:LsdException Locked="false" Priority="39" Name="toc 7" /> <w:LsdException Locked="false" Priority="39" Name="toc 8" /> <w:LsdException Locked="false" Priority="39" Name="toc 9" /> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption" /> <w:LsdException Locked="false" Priority="10" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Title" /> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font" /> <w:LsdException Locked="false" Priority="11" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtitle" /> <w:LsdException Locked="false" Priority="22" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Strong" /> <w:LsdException Locked="false" Priority="20" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Emphasis" /> <w:LsdException Locked="false" Priority="59" SemiHidden="false" UnhideWhenUsed="false" Name="Table Grid" /> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text" /> <w:LsdException Locked="false" Priority="1" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="No Spacing" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 1" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 1" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 1" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 1" /> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision" /> <w:LsdException Locked="false" Priority="34" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="List Paragraph" /> <w:LsdException Locked="false" Priority="29" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Quote" /> <w:LsdException Locked="false" Priority="30" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Quote" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 1" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 1" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 1" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 1" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 1" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 2" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 2" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 2" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 2" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 2" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 2" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 2" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 2" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 2" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 3" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 3" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 3" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 3" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 3" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 3" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 3" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 3" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 3" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 4" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 4" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 4" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 4" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 4" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 4" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 4" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 4" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 4" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 5" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 5" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 5" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 5" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 5" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 5" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 5" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 5" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 5" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 6" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 6" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 6" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 6" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 6" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6" /> <w:LsdException Locked-->

La revista no retiene los derechos de reproducción (copyright) por lo que los autores pueden volver a publicar sus trabajos con la sola mención a la fuente original de publicación.